Ostomy Simulation for Patient Education Prior to Urologic Bowel Diversion Surgeries
Launched by UNIVERSITY OF MINNESOTA · Aug 30, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether using a realistic 3D printed model can help patients learn about caring for their ostomy before their surgery. An ostomy is a procedure that creates an opening in the abdomen for waste to leave the body, and the study aims to see if this model can improve patients' knowledge, skills, and confidence in managing their care. Participants will be divided into two groups: one group will receive education with the 3D model, while the other will get standard education without the model. The study will also look at how these two groups differ in terms of their quality of life, satisfaction with their education, and other health outcomes after their surgery.
To qualify for this trial, participants must be at least 18 years old and scheduled for urologic bowel diversion surgery. Those who already have an ostomy, have cognitive issues that would make it hard to care for the stoma, or are currently pregnant cannot participate. Throughout the study, participants will fill out surveys about their quality of life and satisfaction at different points, including before surgery and after. This research could help improve the support patients receive and enhance their overall experience with ostomy care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age\>18, undergoing bowel diversion urologic surgery.
- Exclusion Criteria:
- • Current or prior ostomy formation, cognitive function causing inability to care for stoma, current pregnancy.
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported